Editas Medicine, Inc.
EDIT · NASDAQ · USD
$2.90
+0.06 2.11%todayNot financial advice.
- Open
- 2.85
- Day range
- 2.71 - 2.97
- 52-week range
- 1.66 - 4.33
- Volume
- 3.09M
- Market cap
- 445.38M
- P/E ratio
- —
- EPS
- -0.74
- Dividend yield
- 0.00%
- Beta
- 2.84
Performance
W
+12.84%
1M
−5.23%
3M
−11.31%
6M
−0.34%
YTD
+40.78%
Y
−31.12%
5Y
−92.49%
All
−83.89%
In the news
Oct 8
Editas Medicine Cleared for First Human Trial of Gene-Editing Cholesterol Drug
Editas Medicine receives clearance to start its first human trial for a gene-editing cholesterol drug, prompting an analyst upgrade.
Company news
Oct 8
Editas Medicine Upgraded by Wells Fargo After Australian Approval for Gene-Editing Trial
Editas Medicine shares rose after Australia approved a Phase 1/2 trial for its gene-editing therapy EDIT-401, prompting a Wells Fargo upgrade.
Company news
Oct 8
Editas Medicine Cleared to Begin Phase 1/2 Trial of EDIT-401 in Australia
Editas Medicine receives approval to start an Australian trial for its cholesterol-lowering treatment EDIT-401 after strong preclinical results.
Company news
Oct 8
Editas Medicine Cleared to Begin Phase 1/2 Trial of EDIT-401 in Australia
Editas Medicine has received Australian clearance to start a Phase 1/2 trial of EDIT-401, marking its first-in-human testing step for the therapy.
Company news
Oct 8
Editas Medicine Receives Approval to Start First Human Trial of Gene-Editing Drug EDIT-401
Editas Medicine has received regulatory approval in Australia to begin its first-in-human Phase 1/2 clinical trial for its hyperlipidemia gene-editing
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-EDIT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Editas Medicine, Inc. (EDIT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-EDIT">EDIT stock price</a> by FreeTheAI Stocks</p>